| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 2.6e-05 | 1 |